Short communication: Behavioral evaluation of the analgesic effect of flunixin meglumine in lame dairy cows

Treatment protocols for claw horn lesions and their impact on lameness recovery, pain sensitivity, and lesion severity in moderately lame primiparous dairy cows

This study aims to investigate the effects of routine treatment protocols for claw horn disruptive lesions (CHDL) on lameness recovery rates, pain sensitivity, and lesion severity in moderately lame primiparous cows. A cohort of first parity cows was recruited from a single commercial dairy herd and randomly allocated to five treatments, comprising four lame groups (LTNB, LTN, LTB, and LT) and a single group non-lame group. Eligibility criteria for the lame cows included a first lameness score (score 3/5), presence of CHDL on a single foot, good body condition score of 3.0 to 3.5, and no history of previous lameness. LTNB received a combination of therapeutic trim, administration of a non-steroidal anti-inflammatory drug (NSAID; Ketoprofen) for 3 days, and hoof block on the healthy claw. Both LTN and LTB received the same treatment as LTNB without hoof block and NSAID, respectively. LT received only a therapeutic trim, whereas non-LT (negative control) received either a therapeutic or preventive trim. Pain sensitivity was assessed using the limb withdrawal reflex while lesion severity was recorded using the International Committee Animal Records (ICAR) Atlas guide. The enrolled cows were observed at weekly intervals, and the primary outcomes were assessed 28 days after treatment. The number (%) of recovered cows was 15 of 20 (75%), 13 of 21 (61.9%), 6 of 14 (42.9%), and 6 of 15 (40%) for LTNB, LTN, LTB, and LT, respectively. LTNB had significantly higher odds of successful treatment (OR = 4.5; 95% 1.1-19.1) compared to LT. Pain sensitivity based on limb withdrawal reflex was absent in a significantly higher number of cows (15/20; 75.0%) in LTNB compared to LTB and LT. LTB had a significantly lower lesion severity score in comparison to LTN. Overall, cows with limb withdrawal at day 28 after treatment were less likely (OR = 0.06; 95% CI 0.01-0.24) to develop a non-lame score. In conclusion, the treatment with therapeutic trim, hoof block, and NSAID led to better recovery and reduced pain sensitivity in moderately lame primiparous cows with good BCS compared to those that received only therapeutic trim. Further research on the changes within the hoof capsule following various treatment protocols is needed to elucidate the clinical benefits observed in this study.

Alteration in Activity Patterns of Cows as a Result of Pain Due to Health Conditions

Simple Summary

There are several conditions and diseases considered painful to cattle. One reason for the inconsistency in pain recognition and thus pain relief in cattle is the inadequate ability to identify and assess pain. In fact, both increased and/or reduced daily lying time can be indicative of pain in cattle. This review helps to properly interpret pain in cows through behavioural activity patterns and explores whether pain relief is capable to restore their normal activity.

Abstract

The main conditions and diseases considered painful in dairy cows are mastitis, lameness, calving (including dystocia and caesarean section) and metritis. The cattle literature reports that deviation from normal daily activity patterns (both increased and/or reduced daily lying time) can be indicative of painful conditions and diseases in cows. This narrative review discusses on how pain due to several health conditions in dairy cows modifies its activity pattern and explores if non-steroidal anti-inflammatory drugs (NSAIDs) are capable of restoring it. Divergent outcomes may differ depending upon the painful cause, the severity and the moment, and consequently its interpretation should be properly explained. For instance, cows with clinical mastitis reduced their time lying and increased the number of lying bouts and stepping due to pain caused by the swollen udder when cows are lying. However, lame cows show longer lying times, with a lower number of lying bouts and longer and more variable lying bouts duration, as compared to non-lame cows. When the relationship between painful disorders and daily activity patterns is studied, factors such as parity, bedding type and severity of disease are important factors to take into consideration. The potential benefits of the NSAIDs treatment in painful health disorders depend upon the type of drug administered, its dosage and administration mode, and the time of administration relative to the painful health disorder. This narrative review can be used as a tool to properly interpret and grade pain in cows through behavioural activity patterns and proposes directions for future investigations.

Chrysin and flunixin meglumine mitigate overloaded copper-induced testicular and spermatological damages via modulation of oxidative stress and apoptosis in rats

This study aimed to evaluate the possible protective actions of chrysin and flunixine meglumine on testicular and spermatological injuries experimentally stimulated by copper. We separated 36 male Sprague-Dawley rats into six equal groups: control, chrysin, flunixine meglumine, copper, copper +chrysin and copper +flunixine meglumine. Chrysin (50 mg/kg/bw/po), flunixine meglumine (2.2 mg/kg/bw/ip) and copper (500 mg/kg/bw/po) were administered day to day for 21 days. Copper administration caused significant morphological, physiological and biochemical alterations compared to the control group, which are as follows: production of oxidative stress, thanks to rise in testis lipid peroxidation and fall in antioxidant enzyme concentrations, decrease in sperm quality and increase in morphologic sperm abnormalities, suppression of spermatogenesis and prominent alterations in the testis histomorphology and induction of apoptosis in the testis tissues. On the other hand, compared to the copper group, treatment with chrysin or flunixine meglumine significantly attenuated these alterations. In conclusion, chrysin and flunixine meglumine have benefits such as antioxidant, antiapoptotic and anti-inflammatory against copper-induced testicular and spermatological damages in rats via the modulation of oxidative stress and apoptosis. Consequently, chrysin is a natural product which has comparable therapeutic actions to flunixine meglumine on the male reproductive system.

A method for assessing sustainability, with beef production as an example

A comprehensive approach to decisions about the use of land and other world resources, taking full account of biological and other scientific information, is crucial for good decisions to be made now and in future. The sustainability of systems for producing food and other products is sometimes assessed using too narrow a range of component factors. A production system might be unsustainable because of adverse effects on a wide range of aspects of human welfare, animal welfare, or the environment. All factors should be included in sustainability evaluation, otherwise products or actions might be avoided without adequate consideration of key factors or of the diversity of production systems. A scoring method that is based on scientific information and potentially of general relevance is presented here, using beef production as a example with a review of each of its sustainability components. This includes an overall combined score and specific factors that make the system unacceptable for some consumers. The results show that, in this example, the sustainability of the best systems is very much better than that of the worst systems. By taking account of scores for a wide range of components of sustainability in comparing beef-production systems, better quality policies about beef use can be formulated than when statements referring only to one system are considered. The least sustainable beef-production systems are extensive grazing that causes land degradation and the use of feedlots or indoor housing with grain feeding. Semi-intensive silvopastoral systems are the most sustainable beef-production systems, and well-managed pasture-fed beef from areas where crop production is uneconomic is also sustainable. This simple, scientifically based scoring system could be modified to use positive as well as negative scores and is of value for policy makers, researchers, producers, organisations aiming to improve sustainability, and the general public.

Analgesic Comparison of Flunixin Meglumine or Meloxicam for Soft-Tissue Surgery in Sheep: A Pilot Study

Simple Summary

Pain management is lacking in U.S. commercial sheep production systems. This is, in part, due to the limited amount of scientific data evaluating sheep pain responses after analgesia treatment. Non-steroidal anti-inflammatory drugs (NSAIDs), such as meloxicam (MEL) and flunixin meglumine (FLU), are the most common drug class provided to livestock species to manage pain. Pain assessment tools, such as facial grimace scales, which use changes in facial expression to monitor pain, are also needed to improve pain management and sheep welfare. In this study, sheep undergoing a laparotomy (a surgical procedure where an incision is made into the abdominal cavity) were treated with either MEL or FLU to manage pain. A third group of ewes did not undergo surgery and served as study controls (CON). Behavior and physiologic outcome measures were collected pre-procedure and up to 48 h post-procedure. The results suggest that MEL and FLU were equally effective at providing post-operative analgesia; however, even with NSAID administration, acute pain and inflammation were still present in surgical sheep compared to non-surgical controls. The facial grimace scale results were not consistent with the other outcome measures taken in this study and it should not be used as a stand-alone pain assessment tool.

Abstract

The amount of scientific data evaluating sheep pain responses after analgesia treatment is limited. The aims of this study were to compare the efficacy of flunixin meglumine (FLU) and meloxicam (MEL) at relieving post-surgical pain in sheep and to evaluate the utility of the Sheep Grimace Scale (SGS). Thirty ewes were assigned to one of three treatment groups: oral MEL or intravenous FLU to manage pain associated with a laparotomy procedure, or a non-surgical control (CON) group. Behavior and physiologic outcome measures were collected pre-procedure and up to 48 h post-procedure. There were no significant differences in behavior, gait, degree of inflammation or pain around the surgical site when MEL and FLU sheep were compared, suggesting that both drugs provided similar levels of analgesia. Significant differences in behavior, gait, abdominal inflammation and pain were found when surgical sheep were compared to non-surgical controls. More work is needed to characterize the amount of pain relief provided by MEL and FLU. The SGS had moderate reliability between scorers; however, the results were inconsistent with the other study outcome measures. The SGS may have some utility as a pain assessment tool but should be used in conjunction with other pain measures.

Short communication: Claw block application improves locomotion and weight-bearing characteristics in cattle with foot diseases

In cattle with foot diseases, application of a block on the healthy partner claw is a common method of pain relief. The aim of this study was to evaluate the effect of wooden claw blocks on locomotion characteristics and weight distribution in healthy (group C; n = 17) versus lame (group L; n = 17) cattle. Group L was further subdivided into group L1 (lameness score ≤3; n = 7) and group L2 (lameness score >3; n = 10). We performed lameness scoring using a numeric rating system and measured locomotion characteristics using 2 accelerometers (400 Hz; kinematic outcome = stance phase duration; kinetic outcomes = foot load and toe-off) and a 4-scale weighing platform (difference of mean weight distribution across the limbs; ∆_weight) before and after application of a claw block. We applied claw blocks to a randomly assigned lateral or medial claw of the fore or hindlimb in group C cows, and on the healthy partner claw in group L cows. Variables were expressed as differences across limbs. We used 1-way ANOVA to determine the differences between groups C and L and between groups L1 and L2 for ∆_weight after application of the claw block. We performed paired t tests to compare variables before and after application of the claw block in groups C and L. Group L scored higher on the numeric rating system than group C (mean ± SD, 3.40 ± 0.62 vs. 1.87 ± 0.28) and showed greater differences in relative stance phase duration (16.34 ± 10.78% vs. 2.13 ± 1.94%), foot load (9.68 ± 8.06 g vs. 3.26 ± 3.69 g), toe-off (3.91 ± 3.14 g vs. 0.78 ± 0.66 g), and ∆_weight (53.62 ± 28.85% vs. 8.52 ± 6.19%). In group C, we observed an increase of 12.17 percentage points in ∆_weight after block application, from 8.52 ± 6.19% to 20.69 ± 17.01%. Compared with the baseline, group L showed a decrease in numeric rating system score (2.88 ± 0.49 vs. 3.40 ± 0.62) and a decrease in differences between the limbs in relative stance phase duration (7.66 ± 9.96% vs. 16.34 ± 10.78%) and foot load (4.26 ± 4.14 g vs. 9.68 ± 8.06 g) after application of a claw block. Group L2 showed smaller ∆_weight after application of a claw block than group L1 (-7.8 ± 8.7% vs. 10.4 ± 7.6%). After block application in group L, we observed smaller differences across the limbs in variables measured to describe gait-cycle characteristics while walking, but no significant improvement while standing. We concluded that application of a claw block must be combined with other methods of pain relief, such as analgesic medication.

The effects of flunixin meglumine and hoof trimming on lying behavior, locomotion, and milk production in lame and nonlame lactating dairy cows

Hoof trimming is used to prevent and treat lameness in dairy cows; however, hoof trimming itself increases daily time spent lying down, possibly due to discomfort. We hypothesized that treatment of lame and nonlame cows with an anti-inflammatory analgesic drug at the time of hoof trimming would mitigate discomfort, thereby improving locomotion scores and reducing post-trimming increases in lying time. We further hypothesized that drug treatment would improve post-trimming milk production. Our objective was to determine the effects of treatment with the nonsteroidal anti-inflammatory drug flunixin meglumine (2.2 mg/kg of BW) at the time of hoof trimming on locomotion, lying times, and milk production in lame and nonlame lactating dairy cows. All cows were filmed for locomotion scoring 1 d before and 1, 8, and 28 d after hoof trimming. Daily time spent standing and lying was recorded for 4 d before and 4 wk after hoof trimming, and daily milk production was recorded for 1 wk before and 8 wk after trimming. Thirty minutes before hoof trimming, an intravenous injection of flunixin meglumine (n = 34) or isotonic sterile saline solution (n = 34) was administered to each cow. Then, all cows had their hooves trimmed using the Dutch method. The same treatment was repeated 24 h after hoof trimming. Cows were categorized using baseline locomotion scores as lame (score ≥3/5) or nonlame (score <3/5). Drug treatment did not affect post-trimming changes in locomotion scores, daily lying times, or milk production. In both treatment groups, most cows had the same lameness status (lame or nonlame) at baseline and after treatment, and there was no difference between groups in the number of cows that changed lameness status over time. Lame cows (n = 21) had no significant changes in lying times over the course of the study, whereas nonlame cows (n = 47) had mean daily lying times that were significantly higher than baseline all 4 wk after trimming. Hoof trimming in nonlame cows should be scheduled for a time when increased lying behavior after trimming can be accommodated.

Timely Euthanasia in the United States Dairy Industry-Challenges and a Path Forward

Euthanasia is a valuable management tool utilized on dairies to end the suffering of sick or debilitated cows. Euthanasia should be implemented if an animal's pain cannot be adequately alleviated and if there is a limited chance of recovery. To be humane, euthanasia should be quick, painless, and administered by a trained individual. Despite its importance in ensuring cow well-being, the timeliness with which euthanasia decisions are made for dairy cattle is often overlooked or neglected. The timeliness of euthanasia is as important as the efficient, rapid administration of euthanasia itself. Timely euthanasia is a critical component of many on-farm animal care and verification programs yet opportunities exist within the industry to improve how effectively the industry is executing this critical component of cow management. There are challenges associated with performing euthanasia in a timely manner, such as inconsistencies in treatment protocols, inadequate employee training, difficulties assessing a cow's quality of life, and impacts of the human-animal bond on decision-making. The objective of this paper is to explain the importance of timely euthanasia to dairy cattle welfare, identify the challenges that can prevent the timeliness of euthanasia, and provide solutions and practical suggestions for improving the management of timely euthanasia on dairies.

Use of validated objective methods of locomotion characteristics and weight distribution for evaluating the efficacy of ketoprofen for alleviating pain in cows with limb pathologies

In veterinary practice pain alleviation plays a part in managing lameness. The aim of this randomized and placebo-controlled clinical study was to evaluate the effect of a single administration of ketoprofen on locomotion characteristics and weight distribution in cattle with foot (located up to and including the fetlock; n = 31) and (proximal to the fetlock; n = 10) pathologies. Cattle were randomly allocated to either the ketoprofen (group K; intravenous 3 mg/kg of body weight; n = 21) or an equivalent volume of isotonic sterile saline solution (group P; n = 20). Two accelerometers (400 Hz; kinematic outcome = stance phase duration; kinetic outcome = foot load and toe-off), a 4-scale weighing platform (weight distribution and SD of the weight) and a subjective locomotion score were measured before (baseline) and after 1 h and 18 h of treatment. All variables were expressed as differences across contralateral limbs, and the measurements at 1 h and 18 h were compared to the baseline. A repeated measures ANOVA was used to determine the differences between groups K and P. A logistic regression model with a binary outcome (0 = no improvement and 1 = improvement of the differences across the contralateral limbs over time) was calculated. Mean (± SD) of locomotion scores at baseline were not significantly different (P = 0.102) in group K (3.10 ± 0.80) as compared to group P (3.48 ± 0.64). Cattle of group K showed significantly lower differences across contralateral limbs at 1 h as compared to group P for the relative stance phase and the weight distribution. Only the treatment (P versus K) remained a significant factor in the model for relative stance phase (odds ratio (OR) = 6.5; 95% CI = 1.38–30.68) and weight distribution (OR = 6.36; 95% CI = 1.30–31.07). The effects of ketoprofen were evident in improving the differences across contralateral limbs—both for stance phase during walking and weight bearing during standing—after 1 h but not after 18 h of administration.

Effects of transdermal flunixin meglumine on experimentally induced lameness in adult dairy cattle

Lameness is a common animal health condition with significant production and welfare implications. The transdermal formulation of flunixin meglumine is the only approved drug for pain control in cattle in the United States. Thirty adult dairy cows were enrolled in a study to determine the effect of transdermal flunixin on cattle with induced lameness. Cows were allocated to 1 of 3 treatment groups, with 10 cows per group: lameness and flunixin (L+F), lameness and placebo (L+P), or sham induction and placebo (S+P). An arthritis-synovitis was induced in the distal interphalangeal joint of the left hind lateral digit, using 20 mg of amphotericin B, 6 h before the application of treatment. Cows enrolled into the sham induction group had 4 mL of isotonic saline injected into the joint. Cows were dosed with transdermal flunixin at 3.33 mg/kg (1 mL/15 kg), or a placebo at 1 mL/15 kg, every 24 h for 3 d. The first treatment of flunixin or placebo was considered the start of the study, identified as time 0 h. Data were collected from all cows for 120 h following the initial treatment application. Outcome measures included plasma cortisol; substance P; visual lameness assessment; mechanical nociception threshold (MNT), presented as difference between left and right feet; infrared thermography (IRT), presented as difference between left and right feet; and gait analysis using a pressure mat. Cortisol concentrations were lower for the L+F group starting at 1.5 h after drug administration. Substance P levels showed no evidence for treatment differences among groups. Differences between the left hind MNT and right hind MNT were detected, with S+P having the lowest difference at -0.04 kilograms-force (kgf; 95% CI: -1.86 to 1.78 kgf), and L+P having the highest at -2.96 kgf (95% CI: 1.55 to 4.36 kgf). The L+F group was intermediate at -2.08 kgf (95% CI: 0.89 to 3.27 kgf). Similarly, when the difference between the maximum temperatures of the coronary band were examined via IRT, the L+P group had the highest difference at 1.64°C (95% CI: 1.02 to 2.26°C), with the L+F and S+P groups measuring 0.57°C (95% CI: 0.06 to 1.08°C) and 0.53°C (95% CI: -0.2 to 1.25°C) respectively. We found no evidence for differences among treatment groups when analyzing force, contact pressure, step impulse, or stride length. Based on differences in MNT, IRT, and cortisol, transdermal flunixin is an effective analgesic agent for induced lameness. Multiple doses of transdermal flunixin may be required to be clinically effective, based on MNT and IRT data. Further investigation of transdermal flunixin and its analgesic effects is warranted in naturally occurring lameness.